CRYSTALLINE RET INHIBITOR
VE6142021000071SUndetermined Publication Date: 2022-02-17LOXO ONCOLOGY INC
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- VE · VE
- Patent Type
- Designs
- Current Assignee / Owner
- LOXO ONCOLOGY INC
- Filing Date
- 2021-04-07
- Publication Date
- 2022-02-17
Need to check novelty before this filing date? Find Prior Art
Description
This document provides a crystalline form of selpercatinib useful in the treatment and prevention of diseases that can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders, and methods for preparing this crystalline form.